Candesartan HCT Zentiva 8/12.5mg
Candesartan HCT Zentiva 8/12.5mg is a medicine authorised by Swissmedic under authorisation number 62321. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 January 2012 and the authorisation is valid without a time limit. ATC code C09DA06 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 62321 |
|---|---|
| Name | Candesartan HCT Zentiva 8/12.5mg |
| Full name | Candesartan HCT Zentiva 8/12.5mg, Tabletten |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DA06 |
| First authorisation | 30 January 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Candesartan HCT Zentiva 8/12.5mg, Tabletten | B | 30 January 2012 |
| 2 | Candesartan HCT Zentiva 16/12.5mg, Tabletten | B | 30 January 2012 |
| 3 | Candesartan HCT Zentiva 32/12.5mg, Tabletten | B | 02 December 2013 |
| 4 | Candesartan HCT Zentiva 32/25 mg, Tabletten | B | 02 December 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 13 | 30 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 14 | 100 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 15 | 30 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 16 | 100 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 17 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 18 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 19 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 20 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Candesartan HCT Zentiva 8/12.5mg authorised in Switzerland?
Yes. Candesartan HCT Zentiva 8/12.5mg is authorised by Swissmedic under authorisation number 62321, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Candesartan HCT Zentiva 8/12.5mg have?
Candesartan HCT Zentiva 8/12.5mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Candesartan HCT Zentiva 8/12.5mg?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.